QCH Report FINAL V2 - Flipbook - Page 12
Queenscourt Hospice (Registered number 2102320)
Report of the Trustees for the year ended 31st March 2024 (continued)
paid an average of 4.85% during the year. However, we will consider other reputable deposit takers if
better rates are available.
The Trustees have wide investment powers, and our other investments are principally in two areas:
CCLA’s COIF Charities Investment Fund and the BlackRock Catholic Charities Growth and Income
Fund. Both funds are invested mainly in equities and aim to at least maintain their real value and to
yield a regular annual income. Income from our investments has yielded around £174,000 and whilst
we continue to seek ways of improving our levels of income, we will not change our conservative view
of risk in order to achieve this. We do not prescribe any requirements for socially responsible
investments other than to avoid tobacco shares.
We also have investments in a property portfolio of 7 houses which are rented, two flats and a shop,
which between them generated a net income of £59,000.
8.
Our Constitution and Administrative Details
Queenscourt’s full name is Queenscourt Hospice. It is a Registered Charity, no. 518801, and a
company limited by guarantee, registered in England No. 2102320 and incorporated in 1987. Its
registered office is at Town Lane, Southport, PR8 6RE. It is not normally liable to taxation.
Queenscourt Hospice has two wholly owned subsidiaries:
• Queenscourt Hospice Enterprises Limited set up in 1993. It operates lotteries. Currently the
chair of the board of its four directors is a member of the Hospice Council.
• Queenscourt Hospice Retail Limited took over the running of our shops on 1 st July 2006.
Currently the chair of the board of its six directors is a member of the Hospice Council.
•
Both companies exist to pay over all their available surpluses to Queenscourt Hospice.
The Council
The members of the Council are the trustees of the charity and directors of the company. The following
are trustees at the date of this report. They all served throughout the year, except where shown
otherwise.
Rev. P M Abrams
Mr A Appleton (from 17th Oct 23 to 3rd May 24)
Ms C Bernard (Co-Chair)
Dr G Boocock
Ms Y Burns (resigned 16th April 2024)
Ms J Campbell
Ms G Causer (from 17th of October 23)
Mr A Crewe (Co-Chair)
Mr C P Cutner (Treasurer)
Dr S Gardner (from 17th of June 2024)
Ms L Hooton
Mrs R Ingham (from 17th June 2024)
Mr D Kemp
Ms H McLaren (from 17th of June 2024)
Mr T McGraw (Co-Chair)
Mrs M H Tarpey (resigned 17th of July 2024)
Mrs A Throp (resigned 17th October 2023)
Mr K B Wallis
Company Secretary: Ms D J Lawson
Executive Directors
Medical Director: Dr Clare Finnegan, MBChB, FRCP, Dip Ethics, PGCert Teaching and Learning in
Clinical Practice. She is a Consultant in Palliative Medicine for Merseycare NHS Foundation Trust and
Mersey and West Lancs Teaching Hospitals NHS Trust, and Honorary Clinical Lecturer University of
Liverpool and Edge Hill University.
Director of Clinical Services: Mrs Louise Charnock, RGN, MSc Advanced Clinical Practice, PG
Certificate in Teaching and Learning in Clinical Practice, BSc (Hons) Specialist Practitioner (District
Nursing), BSc (Hons) Nursing and Health Studies, DipHE Nursing
Director of Corporate Services and Company Secretary: Ms Debra Jane Lawson Dip SW, Dip HE, PG
Certificate in Human Resource Development.
P a g e | 12
